Efficacy and safety of trimethoprim/sulfamethoxazole combined with caspofungin for the treatment of acquired immunodeficiency syndrome patients with moderate to severe pneumocystis pneumonia  

作　　者：何小庆 HE Xiaoqing(Dept Infect Dis,Chongqing Public Health Med Center,Chongqing 400036)

机构地区：[1]Dept Infect Dis,Chongqing Public Health Med Center,Chongqing 400036

出　　处：《China Medical Abstracts(Internal Medicine)》2023年第3期147-148,共2页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To assess the efficacy and safety of trimethoprim/sulfamethoxazole(TMP/SMZ)combined with caspofungin for the treatment of acquired immunodeficiency syndrome(AIDS)patients with moderate to severe pneumocystis pneumonia(PCP)requiring mechanical ventilation.Methods The clinical data of AIDS patients who admitted to Chongqing Public Health Medical Center from March 1,2019 to March 1,2021 with moderate to severe PCP requiring mechanical ventilation were retrospectively analyzed.

关 键 词：IMMUNODEFICIENCY PNEUMONIA TREATMENT 

分 类 号：R512.91[医药卫生—内科学] R563.1[医药卫生—临床医学]